Search
Rallybio Corp
RLYBAdd to Watchlist
17.020USD
+0.030+0.18%
Close 10-09 16:00（ET）
90.21MMarket Cap
LossP/E TTM
Rallybio Corp (RLYB) Stock Price Target & Forecast
Target Price
8.000USD+6.10%
RLYB Analyst Recommendation Trends
In the current month, RLYB has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. RLYB average Analyst price target in the last month is 8.000.
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
0
0
1
1
1
2
3
3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
1
2
4
4
RLYB Analyst Rating for Peer Comparison
Updated: Oct 9, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Beigene Ltd
ONC
8
19
0
0
0
27
argenx SE
ARGX
10
13
3
0
0
26
Ionis Pharmaceuticals Inc
IONS
6
14
5
0
0
25
Insmed Inc
INSM
7
18
0
0
0
25
Kymera Therapeutics Inc
KYMR
9
12
2
0
0
23
Tempus AI Inc
TEM
4
7
11
0
1
23
Revolution Medicines Inc
RVMD
8
13
1
0
0
22
IQVIA Holdings Inc
IQV
8
11
3
0
0
22
Cytokinetics Inc
CYTK
4
16
2
0
0
22
Biontech SE
BNTX
4
13
5
0
0
22
Financial Forecasting
Based on analysts' estimates, RLYB EPS is projected to reach -1.440 in FY2026Q3, following reported EPS of 7.662 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
-1.17
-1.19
-1.28
-1.44
-1.58
Actual
-1.03
-1.46
7.66
--
--
Surprise
+12.24%
-22.08%
+698.57%
--
--
FAQs
What is Rallybio Corp's price target?
Analysts forecast that Rallybio Corp's price target is USD 8.00, with the highest forecast at USD 8.00 and the lowest forecast at USD 8.00.
How have Rallybio CorpRLYB's recent earnings per share performed?
The market expectation was USD 7.66, while Rallybio CorpRLYB's earnings per share (EPS) for the previous quarter was USD -1.46. EPS for the next quarter is expected at USD -1.44.